Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$105.90
0.0%
$112.52
$89.67
$121.64
$183.76B0.765.56 million shs3.61 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.27
-0.4%
$154.19
$143.13
$175.97
$359.25B0.557.47 million shs6.53 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.81
+0.4%
$26.88
$25.20
$40.37
$157.48B0.6343.15 million shs60.57 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.52%-4.73%-5.15%-4.82%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+2.14%-2.05%-4.19%-8.24%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+9.49%+4.31%+4.67%-27.75%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9951 of 5 stars
3.35.04.24.52.62.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.904 of 5 stars
3.23.04.23.93.02.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9934 of 5 stars
4.23.04.24.83.71.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5014.73% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8617.81% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.0029.45% Upside

Current Analyst Ratings

Latest PFE, JNJ, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $29.00
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $36.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
(Data available from 5/6/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.58$6.36 per share16.65$22.36 per share4.74
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.22$13.67 per share10.92$29.09 per share5.13
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.69$2.98 per share9.34$15.81 per share1.76

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2132.9920.682.5513.96%20.32%10.59%7/18/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.3113.662.4645.26%36.70%15.07%7/18/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.111.17-0.56%8.58%3.70%8/6/2024 (Estimated)

Latest PFE, JNJ, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.08%+12.31%68.54%53 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.19%+5.70%29.68%63 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.04%+2.57%N/A 15 Years

Latest PFE, JNJ, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.91
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

PFE, JNJ, and ABT Headlines

SourceHeadline
Pfizer Inc. Expected to Earn FY2024 Earnings of $2.15 Per Share (NYSE:PFE)Pfizer Inc. Expected to Earn FY2024 Earnings of $2.15 Per Share (NYSE:PFE)
americanbankingnews.com - May 6 at 3:16 AM
Pfizer Inc. (NYSE:PFE) to Post Q2 2024 Earnings of $0.48 Per Share, Leerink Partnrs ForecastsPfizer Inc. (NYSE:PFE) to Post Q2 2024 Earnings of $0.48 Per Share, Leerink Partnrs Forecasts
americanbankingnews.com - May 6 at 2:44 AM
Pfizer Inc. (NYSE:PFE) Shares Purchased by Metis Global Partners LLCPfizer Inc. (NYSE:PFE) Shares Purchased by Metis Global Partners LLC
marketbeat.com - May 6 at 12:35 AM
3 No-Brainer Stocks to Buy in May3 No-Brainer Stocks to Buy in May
fool.com - May 5 at 6:55 AM
Pfizer (NYSE:PFE)  Shares Down 0.3% Pfizer (NYSE:PFE) Shares Down 0.3%
americanbankingnews.com - May 5 at 4:38 AM
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming DividendDo These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
finance.yahoo.com - May 4 at 6:18 PM
Ellerson Group Inc. ADV Buys 119,262 Shares of Pfizer Inc. (NYSE:PFE)Ellerson Group Inc. ADV Buys 119,262 Shares of Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 4 at 3:55 PM
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
fool.com - May 4 at 5:17 AM
FY2025 Earnings Estimate for Pfizer Inc. Issued By Leerink Partnrs (NYSE:PFE)FY2025 Earnings Estimate for Pfizer Inc. Issued By Leerink Partnrs (NYSE:PFE)
americanbankingnews.com - May 4 at 4:38 AM
Pfizer Inc. (PFE) Q1 2024 Earnings Call TranscriptPfizer Inc. (PFE) Q1 2024 Earnings Call Transcript
msn.com - May 3 at 11:19 PM
Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost SavingsBuy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings
markets.businessinsider.com - May 3 at 11:19 PM
Pfizer (NYSE:PFE) Stock Price Down 0.3%Pfizer (NYSE:PFE) Stock Price Down 0.3%
marketbeat.com - May 3 at 9:55 PM
Amgens peek at its GLP-1 drug trial results heightens competition in obesity marketAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
finance.yahoo.com - May 3 at 6:19 PM
Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?
stocknews.com - May 3 at 1:17 PM
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With ExpectationsPfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
msn.com - May 3 at 1:16 PM
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJs New Plan to Resolve Talc ClaimsPharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
finance.yahoo.com - May 3 at 1:16 PM
Vanguard Health Care Funds Strategic Moves in Q1 2024: A Focus on Pfizer IncVanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
finance.yahoo.com - May 3 at 1:16 PM
Pfizer Inc. (NYSE:PFE) to Post FY2025 Earnings of $2.93 Per Share, Leerink Partnrs ForecastsPfizer Inc. (NYSE:PFE) to Post FY2025 Earnings of $2.93 Per Share, Leerink Partnrs Forecasts
marketbeat.com - May 3 at 12:53 PM
Heres Why Pfizer (PFE) is a Strong Momentum StockHere's Why Pfizer (PFE) is a Strong Momentum Stock
zacks.com - May 3 at 10:56 AM
Great Valley Advisor Group Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)Great Valley Advisor Group Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 3 at 9:14 AM
NHS to provide Pfizer’s Voxelotor to treat sickle cell diseaseNHS to provide Pfizer’s Voxelotor to treat sickle cell disease
pharmaceutical-technology.com - May 3 at 8:16 AM
Q1 2024 Cardiff Oncology Inc Earnings CallQ1 2024 Cardiff Oncology Inc Earnings Call
finance.yahoo.com - May 3 at 8:16 AM
3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market
investorplace.com - May 3 at 7:00 AM
Pfizer (NYSE:PFE) Shares Up 1.8% on Earnings BeatPfizer (NYSE:PFE) Shares Up 1.8% on Earnings Beat
americanbankingnews.com - May 3 at 2:12 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.